January 17, 2017 1:40 PM ET

Pharmaceuticals

Company Overview of Tolerx, Inc.

Key Executives for Tolerx, Inc.

NameBoard RelationshipsTitleAge
Douglas J. Ringler V.M.D.11 RelationshipsCo-Founder, Chief Executive Officer, President and Director59
Herman Waldmann Ph.D., FRCPath, MRCP, FRS, FMedSci20 RelationshipsCo-Founder, Chairman of the Scientific Advisory Board and Director71

Tolerx, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wayne T. Hockmeyer Ph.D. 42 RelationshipsGenVec, Inc.71
Douglas J. Ringler V.M.D. 11 RelationshipsTolerx, Inc.59
Herman Waldmann Ph.D., FRCPath, MRCP, FRS, FMedSci 20 RelationshipsTolerx, Inc.71
Daniel L. Kisner M.D. 74 RelationshipsAdaptive Therapeutics, Inc.69
James E. Niedel M.D., Ph.D. 55 RelationshipsNew Leaf Venture Partners, L.L.C.72
View All Board Members

Tolerx, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D., FRCPath, MRCP, FRS, FMedSciHerman Waldmann20 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$300.0K
300.0K
389.1K
Bonus$66.6K
66.6K
484.0K
Total Short Term Compensation$5.0M
5.0M
566.4K
Total Value of Options$366.6K
366.6K
15.0M
Compensation as of Fiscal Year 2003
Tolerx, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Evgen Pharma plc Announces Executive Changes
January 17, 2017 7:00 AM ET
Vita Life Sciences Limited Announces Company Secretary Changes
January 17, 2017 5:28 AM ET
GlaxoSmithKline Appoints Hervé Gisserot as its Head of Pharmaceuticals, Asia-Pacific, Based in Singapore
January 17, 2017 12:25 AM ET
Navamedic ASA Announces Management Changes
January 16, 2017 3:22 PM ET
Cumberland Pharmaceuticals Appoints Kenneth J. Krogulski to Board of Directors, Effective January 18, 2017
January 16, 2017 1:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tolerx, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.